{"id":"cpp-acfp","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":{"chemblId":"CHEMBL4297273","moleculeType":"Small molecule","molecularWeight":"213.61"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, I do not have enough information to provide a deeper explanation of the mechanism.","oneSentence":"This drug is a small molecule that targets the [insert target here, if known].","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:07:51.473Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 clinical trials are ongoing for CPP-ACFP, but specific indications are not publicly available."}]},"trialDetails":[{"nctId":"NCT05206539","phase":"PHASE3","title":"Efficacy of Different Agents in Treatment of Initial Caries on Smooth Surfaces in Permanent Teeth in Children","status":"UNKNOWN","sponsor":"Plovdiv Medical University","startDate":"2024-06-01","conditions":"White Spot Lesion of Tooth","enrollment":40},{"nctId":"NCT05204277","phase":"NA","title":"Clinical Evaluation of Dental Fluororsis Treatment Modalities","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2019-09-08","conditions":"Dental Fluorosis","enrollment":16},{"nctId":"NCT05051748","phase":"NA","title":"Clinical Evaluation of Different Minimal Invasive Treatment Modalities of Mild to Moderate Dental Fluorosis Using A Visual Analog Scale","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2019-09-08","conditions":"Dental Fluorosis","enrollment":16},{"nctId":"NCT04776785","phase":"NA","title":"Effect of Self-Assembling Peptides on the Progression of Non-Cavitated Proximal Caries","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2019-10-01","conditions":"Proximal Caries","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":49,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MI varnishTM (GC Corporation, Tokyo, Japan)","RecaldentTM (CPP-ACP)"],"phase":"phase_3","status":"active","brandName":"CPP-ACFP","genericName":"CPP-ACFP","companyName":"Plovdiv Medical University","companyId":"plovdiv-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a small molecule that targets the [insert target here, if known]. Used for Phase 3 clinical trials are ongoing for CPP-ACFP, but specific indications are not publicly available..","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}